Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria--successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibility.
Markiewicz M, Wojciechowska M, Wylezoł I, Woźniczka K, Giebel S, Wojnar J, Krawczyk-Kuliś M, Mendek-Czajkowska E, Hołowiecki J. Markiewicz M, et al. Among authors: wylezol i. Bone Marrow Transplant. 2006 Jan;37(2):231-2. doi: 10.1038/sj.bmt.1705210. Bone Marrow Transplant. 2006. PMID: 16247413 No abstract available.
Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation.
Giebel S, Locatelli F, Wojnar J, Velardi A, Mina T, Giorgiani G, Krawczyk-Kulis M, Markiewicz M, Wylezol I, Holowiecki J. Giebel S, et al. Among authors: wylezol i. Br J Haematol. 2005 Nov;131(4):483-6. doi: 10.1111/j.1365-2141.2005.05797.x. Br J Haematol. 2005. PMID: 16281939 Free article.
Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies.
Helbig G, Stella-Holowiecka B, Wojnar J, Krawczyk M, Krzemien S, Wojciechowska-Sadus M, Markiewicz M, Wylezol I, Kopera M, Holowiecki J. Helbig G, et al. Among authors: wylezol i. Ann Hematol. 2007 Sep;86(9):677-83. doi: 10.1007/s00277-007-0304-8. Epub 2007 May 8. Ann Hematol. 2007. PMID: 17486341
Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient.
Markiewicz M, Wojnar J, Giebel S, Wieczorkiewicz A, Wylezoł I, Hołowiecki J. Markiewicz M, et al. Among authors: wylezol i. Bone Marrow Transplant. 2006 Feb;37(4):433-4. doi: 10.1038/sj.bmt.1705254. Bone Marrow Transplant. 2006. PMID: 16400335 No abstract available.
15 results